Eagle Health Investments’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,214,860
| Closed | -$5.95M | – | 27 |
|
|
2023
Q4 | $5.95M | Hold |
1,214,860
| – | – | 1.21% | 18 |
|
|
2023
Q3 | $6.62M | Hold |
1,214,860
| – | – | 1.46% | 18 |
|
|
2023
Q2 | $8.15M | Hold |
1,214,860
| – | – | 1.52% | 19 |
|
|
2023
Q1 | $10.7M | Buy |
1,214,860
+607,000
| +100% | +$5.36M | 2.09% | 17 |
|
|
2022
Q4 | $4.64M | Sell |
607,860
-607,000
| -50% | -$4.64M | 1.07% | 17 |
|
|
2022
Q3 | $8.65M | Hold |
1,214,860
| – | – | 1.99% | 18 |
|
|
2022
Q2 | $9.83M | Buy |
1,214,860
+200,000
| +20% | +$1.62M | 2.29% | 19 |
|
|
2022
Q1 | $14.1M | Buy |
1,014,860
+264,100
| +35% | +$3.67M | 3.47% | 16 |
|
|
2021
Q4 | $21.1M | Buy |
750,760
+309,294
| +70% | +$8.68M | 5.13% | 6 |
|
|
2021
Q3 | $15M | Buy |
441,466
+183,639
| +71% | +$6.24M | 4.76% | 12 |
|
|
2021
Q2 | $10.5M | Buy |
257,827
+55,607
| +27% | +$2.27M | 3.61% | 14 |
|
|
2021
Q1 | $8.14M | Buy |
202,220
+118,685
| +142% | +$4.78M | 3.2% | 13 |
|
|
2020
Q4 | $4.94M | Buy |
+83,535
| New | +$4.94M | 3.16% | 15 |
|